143 related articles for article (PubMed ID: 19926842)
1. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study.
Kim SJ; Heo KG; Shin HY; Bang OY; Kim GM; Chung CS; Kim KH; Jeon P; Kim JS; Hong SC; Lee KH
Stroke; 2010 Jan; 41(1):173-6. PubMed ID: 19926842
[TBL] [Abstract][Full Text] [Related]
2. Association of moyamoya disease with thyroid autoantibodies and thyroid function: a case-control study and meta-analysis.
Lei C; Wu B; Ma Z; Zhang S; Liu M
Eur J Neurol; 2014 Jul; 21(7):996-1001. PubMed ID: 24684272
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Autoantibodies and the Clinical Presentation of Moyamoya Disease: A Prospective Study.
Lanterna LA; Galliani S; Zangari R; Conti L; Brembilla C; Gritti P; Colleoni ML; Bernucci C
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1194-1199. PubMed ID: 29305275
[TBL] [Abstract][Full Text] [Related]
4. Association of Hyperthyroidism and Thyroid Autoantibodies with Moyamoya Disease and Its Stroke Event: A Population-based Case-control Study and Meta-analysis.
Ahn JH; Jeon JP; Kim JE; Ha EJ; Cho WS; Park YJ; Cho NH; Choi HS; Kang HS; Son YJ; Bang JS; Oh CW
Neurol Med Chir (Tokyo); 2018 Mar; 58(3):116-123. PubMed ID: 29353860
[TBL] [Abstract][Full Text] [Related]
5. Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study.
Li H; Zhang ZS; Dong ZN; Ma MJ; Yang WZ; Han C; Du MM; Liu YX; Yang H; Liu W; Duan L; Cao WC
Stroke; 2011 Apr; 42(4):1138-9. PubMed ID: 21350209
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and disease progression in moyamoya disease patients with Graves disease.
Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
8. Anti-alpha-fodrin autoantibodies in Moyamoya disease.
Ogawa K; Nagahiro S; Arakaki R; Ishimaru N; Kobayashi M; Hayashi Y
Stroke; 2003 Dec; 34(12):e244-6. PubMed ID: 14657555
[TBL] [Abstract][Full Text] [Related]
9. Impact of thyroid autoantibodies on functional outcome in patients with acute ischemic stroke.
Cho HJ; Kim SS; Sung SM; Jung DS
J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1915-20. PubMed ID: 24796663
[TBL] [Abstract][Full Text] [Related]
10. The natural clinical course of hemodynamically stable adult moyamoya disease.
Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
[TBL] [Abstract][Full Text] [Related]
11. Elevated thyroid autoantibodies and intracranial stenosis in stroke at an early age.
Shi Z; Zhang X; Chen Z; Liebeskind DS; Lou M
Int J Stroke; 2014 Aug; 9(6):735-40. PubMed ID: 24024979
[TBL] [Abstract][Full Text] [Related]
12. Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
Stroke; 2020 Aug; 51(8):2472-2479. PubMed ID: 32640948
[TBL] [Abstract][Full Text] [Related]
13. Coexisting diseases of moyamoya vasculopathy.
Wei YC; Liu CH; Chang TY; Chin SC; Chang CH; Huang KL; Chang YJ; Peng TI; Lee TH
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1344-50. PubMed ID: 24468071
[TBL] [Abstract][Full Text] [Related]
14. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
15. Immune response profiling identifies autoantibodies specific to Moyamoya patients.
Sigdel TK; Shoemaker LD; Chen R; Li L; Butte AJ; Sarwal MM; Steinberg GK
Orphanet J Rare Dis; 2013 Mar; 8():45. PubMed ID: 23518061
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia Independently Associated with Adult Moyamoya Disease: Hospital Based Study of 237 Patients.
Zhang Y; Fu X; Zeng X; Xu J; Liu H; Li X; Gao Q
Turk Neurosurg; 2021; 31(2):167-172. PubMed ID: 33216330
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
18. Determinants of Basal Collaterals in Moyamoya Disease: Clinical and Genetic Factors.
Chung JW; Kim SJ; Bang OY; Kim KH; Ki CS; Jeon P; Yeon JY; Kim JS; Hong SC; Shin HJ
Eur Neurol; 2016; 75(3-4):178-85. PubMed ID: 27046023
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
20. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease.
Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1421-8. PubMed ID: 24529354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
